Skip to main content

Table 6 11 C-acetate PET/CT findings resulting in altered treatment strategy

From: 11C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study

Patient number

Localisation pelvic LN metastases

Localisation distant metastases

Synchronous finding

Curative→additional RT

Curative→non-curative RT

1

Iliac int/ext

Paraaortal LN

-

-

Palliative RT

2

Iliac ext

Skeletal

-

-

No RT

3

Iliac int/ext

-

-

RT boost 16 Gy

-

4

Iliac int/ext

 

-

RT boost 16 Gy

-

5

Iliac ext

-

-

RT boost 16 Gy

-

6

Iliac com

 

-

RT boost 16 Gy

-

7

Iliac int/ext

-

-

RT boost 16 Gy

-

8

Obt, iliac int/ext/com

 

-

RT boost 15 Gy

-

9

-

-

HCC with paraaortal LN

-

No RT

10

Iliac ext

 

-

RT boost 20 Gy

-

11

Obt, iliac int/ext/com

Paraaortal LN, skeletal

-

-

No RT

12

Pararectal, iliac ext

-

-

RT boost 26 Gy

-

13

Pararectal, obt, iliac int/ext/com

Paraaortal LN

-

-

Palliative RT

14

Iliac int/ext/com

Paraaortal, thoracic, cervical LN

-

-

No RT

15

-

Skeletal

-

-

No RT

16

Iliac ext

-

-

RT boost 16 Gy

-

17

Iliac ext

Skeletal

-

-

No RT

18

-

-

Aortic aneurysm

-

No RT

19

Pararectal, iliac int/ext/com

Paraaortal, thoracic LN

-

-

No RT

20

Pararectal, obt, iliac ext

-

-

-

Palliative RT

Σ

17

8

2

9

11

  1. HCC, hepatocellular carcinoma; LN, lymph nodes; Obt, obturator; RT, radiotherapy.